AU2003302499A1 - Methods for antigen masking of red blood cells resulting in reduced hemolysis - Google Patents

Methods for antigen masking of red blood cells resulting in reduced hemolysis

Info

Publication number: AU2003302499A1
Authority: AU; Australia
Prior art keywords: methods; blood cells; red blood; cells resulting; reduced hemolysis
Prior art date: 2002-12-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Inventor

Basha Clark

Adonis Stassinopoulos

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cerus Corp

Original Assignee

Cerus Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-04

Filing date

2003-12-03

Publication date

2004-06-23

2003-12-03Application filed by Cerus CorpfiledCriticalCerus Corp

2004-06-23Publication of AU2003302499A8publicationCriticalpatent/AU2003302499A8/en

2004-06-23Publication of AU2003302499A1publicationCriticalpatent/AU2003302499A1/en

StatusAbandonedlegal-statusCriticalCurrent

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0641—Erythrocytes

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Immunology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

AU2003302499A2002-12-042003-12-03Methods for antigen masking of red blood cells resulting in reduced hemolysisAbandonedAU2003302499A1 (en)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US43121402P	2002-12-04	2002-12-04
US43121502P	2002-12-04	2002-12-04
US43121602P	2002-12-04	2002-12-04
US43121302P	2002-12-04	2002-12-04
US60/431,216		2002-12-04
US60/431,215		2002-12-04
US60/431,213		2002-12-04
US60/431,214		2002-12-04
PCT/US2003/038224WO2004050848A2 (en)	2002-12-04	2003-12-03	Methods for antigen masking of red blood cells resulting in reduced hemolysis

Publications (2)

Publication Number	Publication Date
AU2003302499A8 AU2003302499A8 (en)	2004-06-23
AU2003302499A1true AU2003302499A1 (en)	2004-06-23

Family

ID=32475715

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
AU2003297614AAbandonedAU2003297614A1 (en)	2002-12-04	2003-12-03	Novel activated polyethylene glycol compounds
AU2003293237AAbandonedAU2003293237A1 (en)	2002-12-04	2003-12-03	Methods for reacting an antigen masking compound with red blood cells with high efficiency
AU2003302499AAbandonedAU2003302499A1 (en)	2002-12-04	2003-12-03	Methods for antigen masking of red blood cells resulting in reduced hemolysis
AU2003298827AAbandonedAU2003298827A1 (en)	2002-12-04	2003-12-03	Methods for preparing antigen masked red blood cells having reduced hemolysis by sera

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
AU2003297614AAbandonedAU2003297614A1 (en)	2002-12-04	2003-12-03	Novel activated polyethylene glycol compounds
AU2003293237AAbandonedAU2003293237A1 (en)	2002-12-04	2003-12-03	Methods for reacting an antigen masking compound with red blood cells with high efficiency

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU2003298827AAbandonedAU2003298827A1 (en)	2002-12-04	2003-12-03	Methods for preparing antigen masked red blood cells having reduced hemolysis by sera

Country Status (2)

Country	Link
AU (4)	AU2003297614A1 (en)
WO (4)	WO2004050897A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7521174B2 (en)*	2003-12-05	2009-04-21	Albert Einstein College Of Medicine Of Yeshiva University	Universal red blood cells, methods of preparing same, and uses thereof
CN103755949B (en)	2009-12-25	2016-04-13	天津键凯科技有限公司	Multi-arm polyethylene glycol derivative and with the binding substances of medicine and gel
EP3313418B1 (en)	2015-06-26	2024-03-13	Cerus Corporation	Cryoprecipitate compositions and methods of preparation thereof
CA3003097A1 (en)	2015-10-23	2017-04-27	Cerus Corporation	Plasma compositions and methods of use thereof
AU2017382449B2 (en)	2016-12-23	2024-10-24	Cerus Corporation	Systems and methods for testing and screening using compound bound substrates
CA3055203A1 (en)	2017-03-03	2018-09-07	Cerus Corporation	Kits and methods for preparing pathogen-inactivated platelet compositions
US11554185B2 (en)	2017-12-29	2023-01-17	Cerus Corporation	Systems and methods for treating biological fluids
KR20220024691A (en)	2019-06-22	2022-03-03	세루스 코포레이션	biological fluid treatment system
AU2020308035B2 (en)	2019-06-28	2025-07-24	Cerus Corporation	System and methods for implementing a biological fluid treatment device
US20250177448A1 (en)*	2022-03-07	2025-06-05	Icoat Medical Ab	New use of peg-phospholipid molecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL292906A (en)*	1962-10-30
US6312685B1 (en)*	1998-03-13	2001-11-06	Timothy C. Fisher	Red blood cells covalently bound with two different polyethylene glycol derivatives
CN1436083A (en)*	2000-05-31	2003-08-13	塞鲁斯公司	Preparation of pathogen inactivated solution of red blood cells having reduced immunogenicity

2003
- 2003-12-03WOPCT/US2003/038349patent/WO2004050897A2/ennot_activeApplication Discontinuation
- 2003-12-03AUAU2003297614Apatent/AU2003297614A1/ennot_activeAbandoned
- 2003-12-03WOPCT/US2003/038262patent/WO2004050029A2/ennot_activeApplication Discontinuation
- 2003-12-03WOPCT/US2003/038270patent/WO2004049914A2/ennot_activeApplication Discontinuation
- 2003-12-03AUAU2003293237Apatent/AU2003293237A1/ennot_activeAbandoned
- 2003-12-03AUAU2003302499Apatent/AU2003302499A1/ennot_activeAbandoned
- 2003-12-03WOPCT/US2003/038224patent/WO2004050848A2/ennot_activeApplication Discontinuation
- 2003-12-03AUAU2003298827Apatent/AU2003298827A1/ennot_activeAbandoned

Also Published As

Publication number	Publication date
WO2004050897A3 (en)	2004-08-26
AU2003293237A8 (en)	2004-06-23
WO2004050029A2 (en)	2004-06-17
AU2003297614A1 (en)	2004-06-23
WO2004050848A2 (en)	2004-06-17
WO2004049914A2 (en)	2004-06-17
WO2004049914A3 (en)	2005-02-24
WO2004050848A3 (en)	2004-12-09
AU2003297614A8 (en)	2004-06-23
WO2004050897A2 (en)	2004-06-17
AU2003298827A8 (en)	2004-06-23
AU2003302499A8 (en)	2004-06-23
AU2003293237A1 (en)	2004-06-23
AU2003298827A1 (en)	2004-06-23
WO2004050029A3 (en)	2004-10-21

Similar Documents

Publication	Publication Date	Title
EP1554026A4 (en)	2011-02-16	Red blood cell processing systems and methods which control red blood cell hematocrit
AU2003237110A1 (en)	2003-11-10	Improved tubing set for blood handling system and methods of use
AU2003265522A1 (en)	2005-03-10	FCGammaRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
AU2003209059A1 (en)	2003-09-02	Human monoclonal antibodies against membrane proteins
AU2003207973A1 (en)	2003-09-02	Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
AU2003302499A1 (en)	2004-06-23	Methods for antigen masking of red blood cells resulting in reduced hemolysis
AU2002316162A1 (en)	2002-12-03	Method of increasing anti-neugc antibody levels in blood
AU2002950611A0 (en)	2002-09-12	Blood flow analysis system
AU2003243576A1 (en)	2003-12-31	Method and system for detecting ventricular suction
AU2003277610A1 (en)	2004-06-07	Method of examining cancer cells and reagent therefor
AU2002321440A1 (en)	2003-02-24	Expression of modified antibodies in avian cells
EP1341467A4 (en)	2009-11-18	Method for precipitating red blood cells
AU2002319080A1 (en)	2002-12-09	Method for the diagnosis and therapy of renal cell carcinoma
AU2003217743A1 (en)	2003-09-16	Magnetic immobilization of cells
AU2003226441A1 (en)	2003-07-24	Methods of identifying putative effector proteins
AU2003266225A1 (en)	2004-04-08	Obtaining and use of therapeutic antibodies entering into the cell
AU2003258690A1 (en)	2004-04-30	Method for the identification of proteins specific for renal cell carcinoma and use thereof
AU2003901053A0 (en)	2003-03-20	Blood pack and samples pre-id system
AU2002346654A1 (en)	2004-06-30	Dialysis catheter set and method of using same
HK1068095A (en)	2005-04-22	Purification of red blood cells by separation and diafiltration
AU2003905636A0 (en)	2003-10-30	Method of blood collection
AU2002312893A1 (en)	2002-11-18	Method for detecting blood cell antigens and the antibodies in response to the same
AU2003239569A1 (en)	2003-12-12	Analyte microdetector and methods for use
AU2003270518A1 (en)	2004-04-30	Therapeutic anti-bgp(c-cam1) antibodies and uses thereof
AU2002313239A1 (en)	2003-01-02	Method of analyzing protein occurring in cell or substance interacting with the protein

Legal Events

Date	Code	Title	Description
2005-09-22	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

Movatterモバイル変換